1. Home
  2. BIO vs UGI Comparison

BIO vs UGI Comparison

Compare BIO & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • UGI
  • Stock Information
  • Founded
  • BIO 1952
  • UGI 1940
  • Country
  • BIO United States
  • UGI United States
  • Employees
  • BIO N/A
  • UGI N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • UGI Natural Gas Distribution
  • Sector
  • BIO Industrials
  • UGI Utilities
  • Exchange
  • BIO Nasdaq
  • UGI Nasdaq
  • Market Cap
  • BIO 7.7B
  • UGI 7.4B
  • IPO Year
  • BIO N/A
  • UGI N/A
  • Fundamental
  • Price
  • BIO $297.20
  • UGI N/A
  • Analyst Decision
  • BIO Strong Buy
  • UGI Buy
  • Analyst Count
  • BIO 4
  • UGI 3
  • Target Price
  • BIO $333.50
  • UGI $31.33
  • AVG Volume (30 Days)
  • BIO 214.4K
  • UGI 2.3M
  • Earning Date
  • BIO 10-29-2025
  • UGI 11-20-2025
  • Dividend Yield
  • BIO N/A
  • UGI 4.65%
  • EPS Growth
  • BIO N/A
  • UGI N/A
  • EPS
  • BIO 11.49
  • UGI 1.92
  • Revenue
  • BIO $2,554,200,000.00
  • UGI $7,332,000,000.00
  • Revenue This Year
  • BIO $2.12
  • UGI $10.33
  • Revenue Next Year
  • BIO $2.90
  • UGI $16.58
  • P/E Ratio
  • BIO $25.93
  • UGI $16.85
  • Revenue Growth
  • BIO N/A
  • UGI N/A
  • 52 Week Low
  • BIO $211.43
  • UGI $23.14
  • 52 Week High
  • BIO $387.99
  • UGI $37.43
  • Technical
  • Relative Strength Index (RSI)
  • BIO 58.13
  • UGI 33.75
  • Support Level
  • BIO $266.71
  • UGI $32.62
  • Resistance Level
  • BIO $286.84
  • UGI $32.68
  • Average True Range (ATR)
  • BIO 8.86
  • UGI 0.53
  • MACD
  • BIO 2.64
  • UGI -0.01
  • Stochastic Oscillator
  • BIO 71.98
  • UGI 1.94

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

Share on Social Networks: